These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37914146)

  • 1. Towards development of biobetter: L-asparaginase a case study.
    Tripathy RK; Anakha J; Pande AH
    Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
    Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
    ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
    Sugimoto K; Suzuki HI; Fujimura T; Ono A; Kaga N; Isobe Y; Sasaki M; Taka H; Miyazono K; Komatsu N
    Cancer Sci; 2015 Nov; 106(11):1534-43. PubMed ID: 26331698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding targets for a metabolic therapy of cancer: L-asparaginase.
    Covini D; Tardito S; Bussolati O; Chiarelli LR; Pasquetto MV; Digilio R; Valentini G; Scotti C
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):4-13. PubMed ID: 21854356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, Purification, Characterisation and Application of L-ASNase: A Review.
    Paul T; Mondal A; Bandyopadhyay TK
    Recent Pat Biotechnol; 2019; 13(1):33-44. PubMed ID: 30318009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.
    Miranda J; Lefin N; Beltran JF; Belén LH; Tsipa A; Farias JG; Zamorano M
    BioDrugs; 2023 Nov; 37(6):793-811. PubMed ID: 37698749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
    Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumventing the side effects of L-asparaginase.
    Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
    Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-cancer effect using MMP-responsive L-asparaginase fused with cell-penetrating 30Kc19 protein.
    Ryu J; Yang SJ; Son B; Lee H; Lee J; Joo J; Park HH; Park TH
    Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):278-285. PubMed ID: 36191335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
    Avramis VI; Tiwari PN
    Int J Nanomedicine; 2006; 1(3):241-54. PubMed ID: 17717965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).
    Ardalan N; Akhavan Sepahi A; Khavari-Nejad RA
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1137-1147. PubMed ID: 33906306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Design of a Chimeric Humanized L-asparaginase.
    Pedroso A; Herrera Belén L; Beltrán JF; Castillo RL; Pessoa A; Pedroso E; Farías JG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase pharmacology: challenges still to be faced.
    Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):439-450. PubMed ID: 28197753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
    Jarrar M; Gaynon PS; Periclou AP; Fu C; Harris RE; Stram D; Altman A; Bostrom B; Breneman J; Steele D; Trigg M; Zipf T; Avramis VI
    Pediatr Blood Cancer; 2006 Aug; 47(2):141-6. PubMed ID: 16425271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.
    Salzer WL; Asselin BL; Plourde PV; Corn T; Hunger SP
    Ann N Y Acad Sci; 2014 Nov; 1329():81-92. PubMed ID: 25098829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia.
    Dibenedetto SP; Di Cataldo A; Ragusa R; Meli C; Lo Nigro L
    J Clin Oncol; 1995 Feb; 13(2):339-44. PubMed ID: 7844595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.